Project Description

Sigyn
The Evolution of Blood Purification Technologies to Treat Pandemic Threats, Including COVID-19

Date & Time:

June 29, 12:00 PM ET / 9:00 AM PT
Webinar: Details provided upon RSVP approval

About the Event:

Join us for a Fireside Chat with Sigyn CEO, James Joyce and John Vadermosten, senior biotech research analyst with Zacks Investment Research.

They will talk about Sigyn Therapeutics (OTC: SIGY) and the new device the company has developed to treat Cytokine Storm Syndrome which often triggers Sepsis – a disease that inordinately impacts infants, children and the elderly. In addition, COVID-19 is often a trigger for Cytokine Storm Syndrome and still continues to cause hospitalizations and ICU visits for those who contract the disease.

According to The Lancet, there were 48.9 million cases of Sepsis and 11 million deaths globally in 2017. In the United States, Sepsis is the most common cause of in-hospital deaths with annual costs exceeding $24 billion.

Join our Fireside Chat to hear James and John discuss how the company is poised to help save millions of lives and billions of dollars with its breakthrough device.

Share this Event

All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.